Most pharmaceutical supply chains now trace back to China, with its near-monopoly on drug making. But one country is set on fixing the problem, and the United States is poised to benefit. The U.N. high commissioner’s visit to China has come to a close. It drew criticism from human rights groups, who say the organization’s approach to the visit harmed U.N. credibility. Taiwan readies itself for the worst-case scenario. Its military just conducted a round of annual drills involving the launch of various ant
